Complete abstract information will be provided to the CMSC Annual Meeting attendees on May 28, 2023.
| Year | ID | Type | Category | Title | Authors |
|---|
| 2021 | QOL26 | Poster | Quality of Life and Outcomes |
Multiple Sclerosis, Cognition and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability |
Olivia Kaczmarek, BS1, Jack Petroski, Student2, Colette Kodym, Student2, Avtej Sethi, MS2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD1,3, Myassar Zarif, MD1, Daniel Golan, MD4, Jeffrey Wilken, PhD5 and Mark Gudesblatt, MD6, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)Stony Brook University, Stony Brook, NY, (4)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (5)Washington Neuropsychology Research Group, Washington, DC, (6)South Shore Neurologic Associates, P.C., Islip, NY |
| 2021 | QOL27 | Poster | Quality of Life and Outcomes |
Multiple Sclerosis and the Ability to Participate in Social Roles and Activities: Disease Impact Beyond Physical Disability |
Olivia Kaczmarek, BS1, Ellie Teng, Student2, Fatima Khan, Student2, Avtej Sethi, MS2, Barbara Bumstead, MS, ANCP, MSCN2, Marijean Buhse, NP-C, PhD1, Myassar Zarif, MD1, Daniel Golan, MD3, Jeffrey Wilken, PhD4 and Mark Gudesblatt, MD5, (1)South Shore Neurologic Associates, Patchogue, NY, (2)South Shore Neurologic Associates, P.C., Patchogue, NY, (3)Rapparport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel, (4)Washington Neuropsychology Research Group, Washington, DC, (5)South Shore Neurologic Associates, P.C., Islip, NY |
| 2021 | QOL28 | Poster | Quality of Life and Outcomes |
Characterizing Activities of Daily Living in MS Patients with Processing Speed Scores Above and below a Threshold Previously Shown to Predict Employment Status |
Ralph H.B. Benedict, PhD1, Arman Altincatal, MS2, Enrique Alvarez, MD, PhD, MSCI3, Deborah Backus, PT, PhD4, Martin Belkin, DO5, Sophie Cleanthous, PhD6, Joanna Cooper, MD7, Jessica Craddock, MD8, Carl de Moor, PhD2, Emma Elliott, BSc6, John Foley, MD9, Mehul Jhaveri, PharmD, MPH2, Gabriel Pardo, MD, FAAN10, Christopher Perrone, MD11, Pavle Repovic, MD, PhD12, Marvin Rock, -2, Suma Shah, MD13, Barry A Singer, MD14, Jacob A Sloane, MD PhD15, Kyle E. Smoot, MD16, Carlo Tornatore, MD17, Bianca Weinstock-Goodman, MD18 and Irene Koulinska, MD, ScD2, (1)Jacobs Multiple Sclerosis Center, University at Buffalo, Buffalo, NY, (2)Biogen, Cambridge, MA, (3)Department of Neurology, University of Colorado, Aurora, CO, (4)MS Research, Shepherd Center, Atlanta, GA, (5)Michigan Institute for Neuro Disorders, Farmington Hills, MI, (6)Modus Outcomes, Letchworth Garden City, United Kingdom, (7)East Bay Neurology, Walnut Creek, CA, (8)Providence Sacred Heart Medical Center – Spokane, Spokane, WA, (9)Rocky Mountain MS Clinic, Salt Lake City, UT, (10)Oklahoma Medical Research Foundation, Oklahoma City, OK, (11)OMRF Multiple Sclerosis Center of Excellence, Oklahoma Medical Research Foundation, Oklahoma City, OK, (12)Multiple Sclerosis Center, Swedish Neuroscience Institute, Seattle, WA, (13)Neurology, Duke University, Durham, NC, (14)Barnes Jewish Hospital, St Louis, OH, (15)Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA, (16)Providence Multiple Sclerosis Center, Providence Brain and Spine Institute, Portland, OR, (17)Department of Neurology, Medstar Georgetown University Hospital, Washington, DC, (18)Jacobs Multiple Sclerosis Center, University of Buffalo, Buffalo, NY |
| 2021 | QOL29 | Poster | Quality of Life and Outcomes |
A Coach Supported Standardized Approach for Quality Improvement (QI) in the Multiple Sclerosis Continuous Quality Improvement (MS-CQI) Research Collaborative. |
Randall S Messier, MT, MSA, PCMH CCE, RandyMessierLLC, Fairfield, VT, Falguni Mehta, MS, MBA, Department of Community & Family Medicine, Dartmouth Hitchcock Health, Lebanon, NH and Brant J. Oliver, PhD, MS, MPH, APRN-BC, Geisel School of Medicine at Dartmouth, Lebanon, NH |
| 2021 | QOL30 | Poster | Quality of Life and Outcomes |
Trends in Absence Time and Payments Due to Long- and Short-Term Disability and Workers’ Compensation for Employees with Multiple Sclerosis |
Richard A. Brook, MS, MBA, Better Health Worldwide, Inc., Newfoundland, NJ, Nathan L. Kleinman, PhD, WorkPartners, LLC, Cheyenne, WY and Ian A. Beren, BS, WorkPartners, LLC, Loveland, CO |
| 2021 | QOL31 | Poster | Quality of Life and Outcomes |
The Importance of Specialty Pharmacy Services in Multiple Sclerosis Patient Care |
Roma Amin, PharmD, BCACP1, LaTasha Riddick, PharmD, BCACP1, Amy Nathanson, PharmD, BCACP1 and Scott D. Newsome, DO, MSCS, FAAN, FANA2, (1)Johns Hopkins Homecare Group, Baltimore, MD, (2)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD |
| 2021 | QOL32 | Poster | Quality of Life and Outcomes |
Understanding MS Symptoms and Impacts through Semi-Structured Interviews with Clinical Experts and People Living with MS |
Susanne Clinch, PhD1, Fiona McDougall, PhD2, Amy Barrett, MSPH, MA3, Oyebimpe Olayinka-Amao, PharmD, MPH3, Licinio Craveiro, MD, MSc, PhD4, Mike Baker, BSc, MSc4 and Michael Lindemann, MD, PhD4, (1)Roche Products Limited, Welwyn Garden City, United Kingdom, (2)Genentech, Inc., South San Francisco, CA, (3)RTI Health Solutions, Research Triangle Park, NC, (4)F. Hoffmann-La Roche Ltd, Basel, Switzerland |
| 2021 | QOL33 | Poster | Quality of Life and Outcomes |
Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes |
Suzanne Croll, BSc1, Omar M Said, BS1,2, Marta Zholobetska, BS1, Lonni Schultz, PhD3 and Mirela Cerghet, MD, PhD2, (1)Neurology, Henry Ford Hospital, Detroit, MI, (2)School of Medicine, Wayne State University, Detroit, MI, (3)Public Health Science, Henry Ford Health System, Detroit, MI |
| 2021 | QOL35 | Poster | Quality of Life and Outcomes |
Patient-Reported Outcome Measures in Multiple Sclerosis Clinical Trials: Critical Assessment and Insights from People Living with Multiple Sclerosis |
| 2021 | QOL36 | Poster | Quality of Life and Outcomes |
Effects, Tolerance, and Response to COVID-19 Vaccines in Hispanic Puerto Rican Patients with Multiple Sclerosis |
| 2021 | QOL37 | Poster | Quality of Life and Outcomes |
Understanding Health and Well-Being of Women with MS: Implications for Health Care Providers |
Jennifer L Howard, PhD(c)., RN, Faculty of Nursing, Memorial University of Newfoundland, St. John’s, NF, Canada, Yolanda Babenko-Mould, PhD, RN, Health Science-Nursing, Western University, London, ON, Canada, Kimberley Jackson, PhD, RN, Health Science- Nursing, Western University, London, ON, Canada and Tracy Smith-Carrier, PhD, RSW, Social Work, King’s University College at Western University, London, ON, Canada |
| 2021 | QOL38 | Poster | Quality of Life and Outcomes |
Coping Moderates the Association between Symptoms and Functional and Affective Outcomes in the Daily Lives of Individuals with Multiple Sclerosis |
Thomas R Valentine, PhD, Duygu Kuzu, PhD and Anna L Kratz, PhD, Department of Physical Medicine and Rehabilitation, University of Michigan, Ann Arbor, MI |
| 2021 | QOL39 | Poster | Quality of Life and Outcomes |
Multiple Sclerosis Specialist Nurse Care: Patterns of Access and Impact on Health Outcomes |
Belinda Bardsley, RN BN MSCN Dip Management1,2, Therese V Burke, PhD RN CNC3, Jing Chen, PhD4, Bruce Taylor, MD FRACP4, Sue Shapland, RN BN MSCN5 and Ingrid van der Mei, PhD4, (1)Neurology, Austin Health, Heidelberg, VIC, Australia, (2)MS Nurses Australasia Incorporated, Melbourne, Australia, (3)MS Research Australia, North Sydney, Australia, (4)Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia, (5)MSWA, Perth, Australia |
| 2021 | REH09 | Poster | Rehabilitation Poster |
Attitude and Perception of Multiple Sclerosis Patients Toward Exercise |
Ali Fuad Ashour, PhD and Ali Fuad Ashour, PhD, Ministry of Education, Kuwait, Kuwait |
| 2021 | REH10 | Poster | Rehabilitation Poster |
Is Depression Associated with Volume and Pattern of Sedentary Behavior in Persons with Multiple Sclerosis? |
| 2021 | REH11 | Poster | Rehabilitation Poster |
A Scoping Review of Task-Oriented Exercise Effects on Motor Function in People with Multiple Sclerosis |
Eduardo A Toledo-Aldana, BSc, Kristen E Plandowski, BSc and Cameron S Mang, PhD, Kinesiology and Health Studies, University of Regina, Regina, SK, Canada |
| 2021 | REH12 | Poster | Rehabilitation Poster |
Physical Activity Vital Sign in Multiple Sclerosis |
Gloria Hou, MD1, Jami Montagnino, MD1, Marcia Ciol, Ph.D.1 and Cindy Lin, MD1,2, (1)University of Washington, Seattle, WA, (2)The Sports Institute, Seattle, WA |
| 2021 | REH13 | Poster | Rehabilitation Poster |
Difference in Lower Limb Strength Asymmetry between Fallers and Non-Fallers with Multiple Sclerosis |
Heather M DelMastro, MSc1,2, Elizabeth S Gromisch, PhD1,3,4 and Jennifer A. Ruiz, DPT1,4, (1)Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital, Trinity Health Of New England, Hartford, CT, (2)Department of Rehabilitative Medicine, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT, (3)Department of Neurology, University of Connecticut School of Medicine, Farmington, CT, (4)Departments of Rehabilitative Medicine and Medical Sciences, Frank H. Netter MD School of Medicine at Quinnipiac University, North Haven, CT |
| 2021 | REH14 | Poster | Rehabilitation Poster |
Assessing the Benefits of Using Telehealth in Conjunction with a Fitbit to Improve Walking in Veterans with Multiple Sclerosis |
Kelley Volpenhein, PT, DPT1, Amy Banks, PT, DPT, NCS, CBIS1, Lindsay J Riegler, Ph.D.2, Sarah Kiefer-Luhring, MA, CCC-SLP, ATP1 and Amy Kunce, MS, BSRS, CNMT3, (1)Cincinnati VAMC, Cincinnati, OH, (2)Rehab Care Line, Cincinnati VA Medical Center, Cincinnati, OH, (3)Neurology, VAMC, Baltimore, MD |
| 2021 | REH15 | Poster | Rehabilitation Poster |
Occupational Therapy Delivered Emotional Regulation Interventions: A Case-Series of Female Patients with Multiple Sclerosis |
Rebecca Cunningham, OTD, OTR/L, MSCS, Mrs. T.H. Chan Division of Occupational Science & Occupational Therapy, University of Southern California, Los Angeles, CA and Kristin McConnell, MA, OTS, Mrs. T.H. Chan Division of Occupational Science and Occupational Therapy, University of Southern California, Los Angeles, CA |
| 2021 | REH16 | Poster | Rehabilitation Poster |
A Review of Participant Characteristics in Theory-Based Physical Activity Behavior Change Programs in MS: Missing the Greatest Potential for Lifelong Benefits |
Trinh Huynh, MPH1, Stephanie L Silveira, PhD2 and Robert W Motl, PhD1, (1)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)Kinesiology, University of North Texas, Denton, TX |
| 2021 | REH17 | Poster | Rehabilitation Poster |
Needs and Perceptions of a Mobile Application Based on the Canadian Physical Activity Guidelines for Adults with Multiple Sclerosis in the United States |
Whitney N Neal, MA, CHES1, Emma V Richardson, PhD2 and Robert W Motl, PhD1, (1)Physical Therapy, University of Alabama at Birmingham, Birmingham, AL, (2)University of Worcester, Worcester, United Kingdom |
| 2021 | REH18 | Poster | Rehabilitation Poster |
Contradictory Roles of Exercise Participation: A Qualitative Synthesis |
Brynn Adamson, PhD, Health Sciences, University of Colorado Colorado Springs, Colorado Springs, CO and Robert W Motl, PhD, Physical Therapy, University of Alabama at Birmingham, Birmingham, AL |
| 2021 | REH19 | Poster | Rehabilitation Poster |
Validation and Minimal Detectable Change of the Walking While Talking Test As a Measure of Dual-Task Performance in Ambulatory Individuals with Multiple Sclerosis |
David A Henning, PhD1, Erin M Edwards, B.S.1, Melissa Ansara, undergraduate2 and Nora E Fritz, PhD, PT, DPT, NCS1, (1)Neuroimaging and Neurorehabilitation Laboratory, Wayne State University, Detroit, MI, (2)Physical Therapy, Wayne State University, Detroit, MI |
| 2021 | REH20 | Poster | Rehabilitation Poster |
Characterizing the Relationship between Neurological/Mental Health and Physical Activity Levels in Persons with Multiple Sclerosis |
Emily E Tyszka, MPH, Department of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH and Farren B.S. Briggs, PhD, ScM, Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, OH |
| 2021 | REH21 | Poster | Rehabilitation Poster |
Effects of Extended Photobiomodulation Therapy on Muscle Performance in Persons with Relapsing-Remitting Multiple Sclerosis |
Mitra Rouhani, M.S.1, Miguel Tolentino, Ph.D.2, Erik Queoff, M.S.1, Chris Cho, Ph.D.2, Jeri-Anne Lyons, Ph.D.2,3 and Alexander V Ng, PhD4, (1)Marquette University, Milwaukee, WI, (2)University of Wisconsin-Milwaukee, Milwaukee, WI, (3)University of Northern Colorado, Greeley, CO, (4)Exercise Science, Marquette University, Milwaukee, WI |
| 2021 | RTH01 | Poster | Relapse Therapy |
Long-Term Safety of Satralizumab in Neuromyelitis Optica Spectrum Disorder: Results from the Open-Label Extension Periods of Sakurasky and Sakurastar |
| 2021 | RTH02 | Poster | Relapse Therapy |
Results from a Multicenter, Randomized, Double Blind, Placebo-Controlled Study of Repository Corticotropin Injection for Relapsing-Remitting Multiple Sclerosis |
Daniel Wynn, MD1, Lawrence P Goldstick, MD2, William Bauer, MD, PhD3, Enxu Zhao, MS4, Eva Tarau, MD4, Jeffrey A. Cohen, MD5, Derrick Robertson, MD6 and Aaron E Miller, MD7, (1)Consultants in Neurology MS Center, Northbrook, IL, (2)Waddell Center for Multiple Sclerosis, University of Cincinnati, Cincinnati, OH, (3)Department of Neurosciences, University of Toledo, Toledo, OH, (4)Mallinckrodt Pharmaceuticals, Hampton, NJ, (5)Department of Neurology, Mellen MS Center, Neurological Instiute,Cleveland Clinic, Cleveland, OH, (6)University of South Florida, Morsani College of Medicine, Tampa, FL, (7)Icahn School of Medicine at Mount Sinai, The Corinne Goldsmith Dickinson Center for Multiple Sclerosis, New York, NY |
| 2021 | SEC01 | Poster | Self-care |
Summary of Diet Intervention Studies in Multiple Sclerosis from the National MS Society Nutrition Wellness Subgroup |
Rebecca I Spain, MD, MSPH, Oregon Health & Science University, Portland, OR; VA Portland Health Care System, Portland, OR, Mona Bostick, RDN, LDN, MSCS, NA, Greensboro, NC, Patrizia Casaccia, MD, PhD, Advanced Science Research Center, City University of New York, New york, NY, Kathryn C Fitzgerald, ScD, Johns Hopkins Medicine, Department of Neurology, Baltimore, MD, Barbara Giesser, MD, Neurology, UCLA, Los Angeles, CA, Ellen M Mowry, MD, MCR, Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, Laura Piccio, MD/PhD, Neurology, Washington University, St Louis, MO, Terry L. Wahls, MD, Department of Internal Medicine, University of Iowa, Iowa City, IA, Brooks C Wingo, PhD, Department of Occupational Therapy, University of Alabama, Birmingham, AL, Vijayshree Yadav, MD, Neurology, Oregon Health & Science University, Portland, OR, Kathleen M Zackowski, PhD, OT, Motion Analysis Laboratory, Kennedy Krieger Institute, Baltimore, MD and Ilana Katz Sand, MD, Neurology, The Mount Sinai Hospital, New York, NY |
| 2021 | SXM01 | Poster | Symptom Management |
Arbaclofen Extended-Release for the Treatment of Spasticity in Multiple Sclerosis: A Randomized, Multi-Center, Placebo-Controlled Clinical Trial (Study OS440-3004) |
Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL, Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN, Mark Jaros, PhD, Summit Analytical, Denver, CO, Tina deVries, PhD, Osmotica Pharmaceuticals, Bridgewater, NJ and Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX |
| 2021 | SXM02 | Poster | Symptom Management |
The Effect of Hypnotics and Stimulants on Fatigue, Sleep, and Quality of Life Outcomes in a Multiple Sclerosis Cohort |
Daniela A Pimentel Maldonado, MD1, Loulwah Mukharesh, MD2, Chen Hu, MS1, Ellen M Mowry, MD, MCR1, Bardia Nourbakhsh, MD1 and Kathryn C Fitzgerald, ScD1, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Neuro-Ophthalmology, Massachusetts Eye and Ear Institute, Boston, MA |
| 2021 | SXM03 | Poster | Symptom Management |
Arbaclofen Extended-Release for the Treatment of Spasticity in Multiple Sclerosis: An Open-Label Safety Study (Study OS440-3005) |
Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX, Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL, Mark Jaros, PhD, Summit Analytical, Denver, CO, Tina deVries, PhD, Osmotica Pharmaceuticals, Bridgewater, NJ and Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN |
| 2021 | SXM04 | Poster | Symptom Management |
Nabiximols, a Cannabis-Based Complex Botanical Mixture and MS Spasticity: How Does It Work? |
Kathryn Nichol, PhD, Greenwich Biosciences, Inc., Carlsbad, CA and Royston Gray, PhD, Pharmacology Scientist, GW Research Ltd, London, United Kingdom |
| 2021 | SXM05 | Poster | Symptom Management |
Systematic Review of Real-World Evidence on the Effect of Nabiximols on Pain and Sleep Impairment in Persons with MS (PwMS) Experiencing Spasticity |
Mary A. Willis, MD1, Kate Nichol, PhD2 and Kelly Hollenack, PharmD2, (1)Department of Neurology, University of Mississippi Medical Center, Jackson, MS, (2)Greenwich Biosciences, Inc., Carlsbad, CA |
| 2021 | SXM06 | Poster | Symptom Management |
Identifying and Characterizing Fatigue in Patients Diagnosed with Multiple Sclerosis on Disease-Modifying Therapies Using Real World Evidence |
Thomas P. Leist, MD1, Michele Cole, PharmD, MS2, Hoa Le, PhD3, Sumit Verma, BPharm, MS4 and Alex Keenan, MS2, (1)Comprehensive Multiple Sclerosis Center, Division of Clinical Neuroimmunology, Jefferson University, Philadelphia, PA, (2)Research and Development, Janssen Pharmaceuticals, Titusville, NJ, (3)Janssen Scientific Affairs, Janssen Pharmaceuticals, Titusville, NJ, (4)Health Economics and Outcomes Research, StatInMed, Plano, TX |
| 2021 | SXM07 | Poster | Symptom Management |
Is a Light Hand on the Wheels Enough? Postural Sway in Standing with Different Methods of Walker Use in Multiple Sclerosis and Controls |
Najala Orrell, MD1, Pawan Kumar, PhD Student2, Alison Oates, PhD2, Joel Lanovaz, PhD2, Michael Levin, FRCPC3, Aman Saini, MD3 and Katherine Knox, FRCPC1, (1)Department of Physical Medicine and Rehabilitation, University of Saskatchewan, Saskatoon, SK, Canada, (2)College of Kinesiology, University of Saskatchewan, Saskatoon, SK, Canada, (3)Office of the Saskatchewan Multiple Sclerosis Clinical Research Chair, University of Saskatchewan, Saskatoon, SK, Canada |
| 2021 | SXM08 | Poster | Symptom Management |
Sources of Cannabis Information and Medical Guidance Among People with Multiple Sclerosis: Narcoms Survey Results |
Robert J. Fox, MD1, Amber Salter, PhD2, Gary Cutter, PhD3, Joshua R. Steinerman, MD4, Kate Nichol, PhD4 and Karry Smith, PhD, MPH4, (1)Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, (2)Washington University School in St. Louis, St Louis, MO, (3)The University of Alabama at Birmingham, Birmingham, AL, (4)Greenwich Biosciences, Inc., Carlsbad, CA |
| 2021 | SXM09 | Poster | Symptom Management |
Arbaclofen Extended-Release for Spasticity in Multiple Sclerosis: Responder Analysis of a Phase 3 Randomized, Placebo-Controlled Clinical Study OS440-3004 |
Samuel F Hunter, MD, PhD, Advanced Neurosciences Institute, Franklin, TN, Daniel Kantor, MD, FAAN, FANA, Florida Atlantic University, Boca Raton, FL, James L Rogers, PhD, Summit Analytical LLC, Denver, CO, Tina deVries, PhD, Osmotica Pharmaceuticals, Bridgewater, NJ and Darin T Okuda, MD, UT Southwestern Medical Center, Dallas, TX |
| 2021 | SXM10 | Poster | Symptom Management |
Symptom Burden and Treatment Goals of People with MS Spasticity: Results from SEEN-MSS, a Large-Scale, Self-Reported Survey |
Scott D. Newsome, DO, MSCS, FAAN, FANA1, Ben Thrower, MD2, Barry Hendin, MD3, Joanne Wagner, PT, PhD4, Sherry Danese, PhD5 and Jenifer Patterson, ARNP, MSCN4, (1)Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, (2)Andrew C. Carlos MS Institute, Shepherd Center, Atlanta, GA, (3)Neurology, University of Arizona, Tucson, AZ, (4)Greenwich Biosciences, Carlsbad, CA, (5)Outcomes Insights, Agoura Hills, CA |
| 2021 | SXM11 | Poster | Symptom Management |
Implementation of a Depression Screening Tool (PHQ-9) for Adult Multiple Sclerosis Patients at an Outpatient Neurology Clinic. |
Selina Yeasmin, CRNP, Outpatient Neurology Department, UMMC, Baltimore, MD and Lori Edwards, DrPH, BSN, RN |